108 results
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
of 2016, Mr. Neugeboren has served as the Chief Strategy Officer of Cronus Pharma, LLC, a fully integrated R&D, manufacturing and sales & marketing … April 2022 until May 2023 and as Program Leader and Associate Director - R&D at Grace Therapeutics between March 2015 and January 2022. Mr. Kumar received
8-K
euv5bi 1j
11 May 23
Departure of Directors or Certain Officers
4:50pm
424B5
kcr5z klyb2al32d
10 Nov 21
Prospectus supplement for primary offering
7:23am
8-K
EX-99.1
1knwwi87v
10 Nov 21
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022
7:09am
8-K
EX-99.2
npxuywb 8thlqwicj1
21 Jul 21
Other Events
5:17pm
8-K
EX-99.1
sq2p489uqchv135f2
21 Jul 21
Other Events
5:17pm
425
EX-99.1
p5k dnktv
21 Jul 21
Business combination disclosure
5:15pm